Home / SETD2 Knockout Cell Lines

SETD2 Knockout Cell Lines

Gene: SETD2

Official Full Name: SET domain containing 2, histone lysine methyltransferaseprovided by HGNC

Gene Summary: Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00154 SETD2 Knockout cell line (293T) Human SETD2 1:3~1:6 Negative Online Inquiry
KO00922 SETD2 Knockout cell line(CNE1) Human SETD2 1:3~1:5 Negative Online Inquiry
KO14195 SETD2 Knockout cell line (HeLa) Human SETD2 1:3~1:6 Negative Online Inquiry
KO14196 SETD2 Knockout cell line (HCT 116) Human SETD2 1:2~1:4 Negative Online Inquiry
KO14197 SETD2 Knockout cell line (HEK293) Human SETD2 1:3~1:6 Negative Online Inquiry
KO39185 SETD2 Knockout cell line (A549) Human SETD2 1:3~1:4 Negative Online Inquiry

Background

SETD2 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone targeted gene disruption of the SETD2 gene, which is crucial for the regulation of gene expression and DNA repair. This gene is a key player in maintaining genomic stability and its dysfunction is implicated in various cancers. By creating a knockout model, researchers can investigate the biological roles of SETD2, as well as its involvement in tumorigenesis and response to therapeutic agents.

The primary function of these cell lines is to facilitate the study of the SETD2 gene’s contributions to cellular processes such as methylation of histones, chromatin remodeling, and DNA damage repair pathways. The absence of SETD2 allows researchers to observe altered cellular behaviors, providing insights into oncogenic mechanisms and potential therapeutic targets. Techniques such as CRISPR-Cas9 or RNA interference are commonly utilized in the development of these knockout models, ensuring precise gene editing that enhances experimental reproducibility.

The scientific relevance of SETD2 Gene Knockout Cell Lines spans multiple domains, from basic cellular biology and molecular genetics to translational research and drug development. In clinical settings, understanding how SETD2 loss contributes to cancer development could lead to novel biomarkers for cancer prognosis or new therapeutic strategies targeting SETD2-related pathways.

What sets our SETD2 Gene Knockout Cell Lines apart from alternative models is the robust characterization and validation processes they undergo, ensuring high specificity and reproducibility in results. Unlike generic knockout systems, our lines come with comprehensive phenotypic profiling that enhances their reliability for various experimental designs.

For researchers and clinicians focused on cancer biology or genomic studies, these knockout models are invaluable tools that can significantly advance understanding of SETD2-related pathways. Leveraging our expertise in cellular engineering, we provide high-quality biological products that are essential for pioneering research and developing groundbreaking clinical applications in the life sciences arena.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.